newsfilter
← Latest News
GlobeNewswire·

Boundless Bio Reports Second Quarter 2025 Financial Results and Business Highlights

BBI-355 and BBI-825 combination arm of the POTENTIATE trial is now open for enrollment BBI-940 is on track for submission of an investigational new drug application in the first half of 2026 $127